No Data
No Data
Express News | Relmada Therapeutics Inc Files for Mixed Shelf of up to $250 Mln - SEC Filing
Will Relmada Therapeutics (NASDAQ:RLMD) Spend Its Cash Wisely?
Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD) and Neumora Therapeutics, Inc. (NMRA)
Earnings Call Summary | Relmada Therapeutics(RLMD.US) Q2 2024 Earnings Conference
Optimistic Outlook for Relmada Therapeutics: Strategic Trial Enhancements and Solid Financial Position
Express News | Relmada Therapeutics Shares Are Trading Lower. The Company Reported Q2 Financial Results
No Data
BooBooG : cannot